This pilot project evaluated whether targeted training could strengthen clinical research capacity at community cancer centers, improve readiness to conduct oncology trials, and support more inclusive ...

Baystate Health announces the appointment of Dr. Matthew D. Di Guglielmo, as the new chair of the Department of Pediatrics at ...

VIENTIANE: When Katy walks into the University of Health Sciences each morning, she carries more than her notebook and lesson ...

The agency’s budget has grown steadily since the 1960s, fueling an industry that creates lifesaving medicines and attracts ...

The world's first single-dose vaccine to prevent dengue fever has been approved for licensure in one of the largest countries ...

THE COMPANY EXPECTS TO RELEASE TOPLINE RESULTS FOR SKNJCT-003 PHASE 2 CLINICAL TRIAL BEFORE THE END OF Q1 2026 AND REQUEST END-OF-PHASE 2 (EOP2) ...

LRK-4189, which targets PIP4K2C, a key cancer cell fitness target, is being developed for microsatellite stable (MSS) ...

Vermont Business Magazine The world’s first single-dose vaccine to prevent dengue fever was approved for licensure following ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...

President Cunningham’s “All Minnesota” plan, developed in partnership with statewide providers, is the better path.

Tennessee Oncology, which treats nearly half of the cancer patients in the Volunteer State, is proud to announce that John Phillips, MD, MPH has been appointed Executive Vice President of Radiation ...